Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRASTUZUMAB-ANNS Cause Left ventricular dysfunction? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Left ventricular dysfunction have been filed in association with TRASTUZUMAB-ANNS. This represents 0.7% of all adverse event reports for TRASTUZUMAB-ANNS.

10
Reports of Left ventricular dysfunction with TRASTUZUMAB-ANNS
0.7%
of all TRASTUZUMAB-ANNS reports
0
Deaths
0
Hospitalizations

How Dangerous Is Left ventricular dysfunction From TRASTUZUMAB-ANNS?

Of the 10 reports.

Is Left ventricular dysfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB-ANNS. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does TRASTUZUMAB-ANNS Cause?

Product storage error (346) Circumstance or information capable of leading to medication error (257) Off label use (104) Intercepted product administration error (89) Product dose omission issue (68) Chills (58) Dyspnoea (52) Nausea (49) Diarrhoea (48) Rash (45)

What Other Drugs Cause Left ventricular dysfunction?

DOXORUBICIN (430) CYCLOPHOSPHAMIDE (426) TRASTUZUMAB (401) CLOZAPINE (231) SACUBITRIL\VALSARTAN (231) BISOPROLOL (225) PERTUZUMAB (207) RITUXIMAB (202) DOCETAXEL (199) VINCRISTINE (193)

Which TRASTUZUMAB-ANNS Alternatives Have Lower Left ventricular dysfunction Risk?

TRASTUZUMAB-ANNS vs TRASTUZUMAB DERUXTECAN TRASTUZUMAB-ANNS vs TRASTUZUMAB-DKST TRASTUZUMAB-ANNS vs TRASTUZUMAB-DTTB TRASTUZUMAB-ANNS vs TRASTUZUMAB EMTANSINE TRASTUZUMAB-ANNS vs TRASTUZUMAB-PKRB

Related Pages

TRASTUZUMAB-ANNS Full Profile All Left ventricular dysfunction Reports All Drugs Causing Left ventricular dysfunction TRASTUZUMAB-ANNS Demographics